Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-21-054828)

Filing Details

Accession Number:: 0001209191-21-054828
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-09-03 17:23:19
Reporting Period:: 2021-09-01

Accepted Time:: 2021-09-03 17:23:19
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1107421	Ziopharm Oncology Inc	ZIOP	Pharmaceutical Preparations (2834)	841475642

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1846984	Holger Weis	C/O Ziopharm Oncology, Inc. One First Avenue, Parris Bldg 34 Boston MA 02129		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-09-01	50,000	$1.83	120,167	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	19,000	Indirect	By spouse
Common Stock	1,000	Indirect	By child
Common Stock	1,240	Indirect	By child
Common Stock	200	Indirect	By child

Footnotes

Includes 30,000 shares held in a joint account by the Reporting Person and his spouse.